TNFSF10 and cancer: Furthermore, some cancer cells, including some types of TNBC, are intrinsically resistant to TRAIL, while others are initially sensitive to TRAIL but later acquire resistance through various mechanisms, including overexpression of members of the anti-apoptotic Bcl-2 family [26–37].